251 related articles for article (PubMed ID: 12094381)
1. Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma.
Brown HM; Wilkinson EJ
Hum Pathol; 2002 May; 33(5):545-8. PubMed ID: 12094381
[TBL] [Abstract][Full Text] [Related]
2. Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease.
Wilkinson EJ; Brown HM
Hum Pathol; 2002 May; 33(5):549-54. PubMed ID: 12094382
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.
Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC
Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry of p63 in primary and secondary vulvar Paget's disease.
Yanai H; Takahashi N; Omori M; Oda W; Yamadori I; Takada S; Matsuura H; Yoshino T
Pathol Int; 2008 Oct; 58(10):648-51. PubMed ID: 18801085
[TBL] [Abstract][Full Text] [Related]
5. Cytology of secondary vulvar Paget's disease of urothelial origin: a case report.
Brown HM; Wilkinson EJ
Acta Cytol; 2005; 49(1):71-4. PubMed ID: 15717759
[TBL] [Abstract][Full Text] [Related]
6. Invasive Extramammary Paget Disease of the Vulva With Signet Ring Cell Morphology in a Patient With Signet Ring Cell Carcinoma of the Stomach: Report of a Case.
Jeong BK; Kim KR
Int J Gynecol Pathol; 2018 Mar; 37(2):147-151. PubMed ID: 28582341
[TBL] [Abstract][Full Text] [Related]
7. Vulvar Paget disease secondary to high-grade urothelial carcinoma with underlying massive vascular embolization and cervical involvement: case report of unusual presentation.
Primo WQSP; Primo GRP; Basilio DB; Machado KK; Carvalho JP; Carvalho FM
Diagn Pathol; 2019 Nov; 14(1):125. PubMed ID: 31699107
[TBL] [Abstract][Full Text] [Related]
8. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
[TBL] [Abstract][Full Text] [Related]
9. The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget's disease.
Ohnishi T; Watanabe S
Br J Dermatol; 2000 Feb; 142(2):243-7. PubMed ID: 10730755
[TBL] [Abstract][Full Text] [Related]
10. GATA3 expression in primary vulvar Paget disease: a potential pitfall leading to misdiagnosis of pagetoid urothelial intraepithelial neoplasia.
Morbeck D; Tregnago AC; Baiocchi G; Sacomani C; Peresi PM; Osório CT; Schutz L; Bezerra SM; de Brot L; Cunha IW
Histopathology; 2017 Feb; 70(3):435-441. PubMed ID: 27633145
[TBL] [Abstract][Full Text] [Related]
11. Paget phenomenon of the vulva with histopathological features of high-grade urothelial carcinoma (transitional cell carcinoma).
Kurashige Y; Minemura T; Nagatani T
Eur J Dermatol; 2013; 23(4):556-7. PubMed ID: 23985168
[No Abstract] [Full Text] [Related]
12. Pagetoid squamous cell carcinoma in situ (pagetoid Bowen's disease) of the external genitalia.
Raju RR; Goldblum JR; Hart WR
Int J Gynecol Pathol; 2003 Apr; 22(2):127-35. PubMed ID: 12649666
[TBL] [Abstract][Full Text] [Related]
13. Differences in expression of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine proliferative urothelial lesions of the urinary bladder.
Sledge DG; Patrick DJ; Fitzgerald SD; Xie Y; Kiupel M
Vet Pathol; 2015 Jan; 52(1):74-82. PubMed ID: 24608632
[TBL] [Abstract][Full Text] [Related]
14. Unusual Manifestations of Vulval Paget Disease.
Shah VI; Bergin L; Rowlands GL; McCluggage WG
Int J Gynecol Pathol; 2022 Sep; 41(5):476-483. PubMed ID: 34570018
[TBL] [Abstract][Full Text] [Related]
15. Histogenesis of extramammary and mammary Paget cells. An immunohistochemical study.
Guarner J; Cohen C; DeRose PB
Am J Dermatopathol; 1989 Aug; 11(4):313-8. PubMed ID: 2549798
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder.
Borhan WM; Cimino-Mathews AM; Montgomery EA; Epstein JI
Am J Surg Pathol; 2017 Nov; 41(11):1570-1575. PubMed ID: 28786878
[TBL] [Abstract][Full Text] [Related]
17. Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer.
Gaisa NT; Braunschweig T; Reimer N; Bornemann J; Eltze E; Siegert S; Toma M; Villa L; Hartmann A; Knuechel R
Virchows Arch; 2011 Mar; 458(3):301-12. PubMed ID: 21136076
[TBL] [Abstract][Full Text] [Related]
18. Vulvar pagetoid urothelial intraepithelial neoplasia: a case report.
Boret S; Lambert E; Charles VP; Philippe T; Ponette D; Darras J; Mattelaer P; Verbeke S; Lumen N; Decaestecker K
Acta Chir Belg; 2023 Apr; 123(2):174-177. PubMed ID: 34134597
[TBL] [Abstract][Full Text] [Related]
19. TRPS1 expression is sensitive and specific for primary extramammary Paget disease.
Cook EE; Harrison BT; Hirsch MS
Histopathology; 2023 Jul; 83(1):104-108. PubMed ID: 36971374
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in Paget's disease of the vulva: a study of 21 cases.
Crawford D; Nimmo M; Clement PB; Thomson T; Benedet JL; Miller D; Gilks CB
Int J Gynecol Pathol; 1999 Oct; 18(4):351-9. PubMed ID: 10542944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
